| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/30/2002 | WO2001094562A3 Cold sensitive mutant dna polymerases |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001092580A3 Lyophilizable and enhanced compacted nucleic acids |
| 05/30/2002 | WO2001092565A8 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001079541A3 Improvements in and relating to analysis of dna samples |
| 05/30/2002 | WO2001079238A3 Haplotypes of the mmp3 gene |
| 05/30/2002 | WO2001073440A3 Detection of diarrhoeogenic e.coli germs |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001047638A3 Integrated microfluidic disc |
| 05/30/2002 | WO2001046467A3 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |
| 05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001042508A9 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/30/2002 | WO2001037194A9 Crystallizable compositions comprising a caspase-7 |
| 05/30/2002 | WO2001036662A3 Hydrolytic enzyme substrates and assay method |
| 05/30/2002 | WO2001031064A3 Relation of apolipoprotein e genotype and estrogen deprivation in alzheimer's disease |
| 05/30/2002 | WO2001031058A3 Identification of cells for transplantation |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2001020037A3 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism |
| 05/30/2002 | WO2001011373A8 Difference detection methods using matched multiple dyes |
| 05/30/2002 | WO2001007908A3 Improvements in and relating to forensic investigations |
| 05/30/2002 | WO2001007664A3 Genome analysis |
| 05/30/2002 | WO2001006249A3 Organic semiconductor recognition complex and system |
| 05/30/2002 | WO2001004360A3 Retroviral recombination assays and uses thereof |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000075366A3 Transcription-based gene mapping |
| 05/30/2002 | WO2000061800A8 Method for the analysis of aflp® reaction mixtures using primer extension techniques |
| 05/30/2002 | WO2000052205A8 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 05/30/2002 | US20020066118 Microsatellite markers for plants of the species triticum aestivum and tribe triticeae and the use of said markers |
| 05/30/2002 | US20020065609 Methods for the survey and genetic analysis of populations |
| 05/30/2002 | US20020065538 Method and device for recording polarized electromagnetic radiation of inactivated strain of pathogenic microorganisms onto a crystal, method and device for changing activity of strain of pathogenic microorganisms, method for eliminating strain of pathogenic microorganisms from human or animal organism |
| 05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065225 Methods of determining altered NDPK functions and the diagnosis of cystic fibrosis |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064879 Method for obtaining a plant with a genetic lesion in a gene sequence |
| 05/30/2002 | US20020064869 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents |
| 05/30/2002 | US20020064861 Identification of virulence determinants |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064850 Nucleotide sequences for use in generating fructose polymers for food processing |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064838 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 05/30/2002 | US20020064837 Kit for biosynthesis of nucleotide sequences |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064824 Generating preferential binding protein; obtain nucleotide sequences, replace preferential nucleotides, translate nucleotide sequences, recover preferential protein |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064819 Polypeptide for use in the treatament and prevention of nervous system disorders |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064809 Cell separation method; detect preferential acoustic impedance at surface of fluid, determine physical properties of fluid, discharge fluid |
| 05/30/2002 | US20020064808 Focused acoustic energy for ejecting cells from a fluid |
| 05/30/2002 | US20020064806 Methods and compositions for glycosidase assays |
| 05/30/2002 | US20020064804 Detecting cyclooxygenase activity in cells; obtain sample, monitor sample for cycloxygenase metabolites, the presence of a specific metabolite indicates cycloxygenase activity |
| 05/30/2002 | US20020064802 Associating protein with chromosomes; monitor chromosome, detect target association position, transform cell, detect proteins association with chromosome |
| 05/30/2002 | US20020064799 Proteomic analysis |
| 05/30/2002 | US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles |
| 05/30/2002 | US20020064795 Nucleic acid detection method and apparatus, and vessel for detecting nucleic acid |
| 05/30/2002 | US20020064793 Screen for compounds with affinity for nucleic acids |
| 05/30/2002 | US20020064791 Detection of unlabeled hybridized DNA and RNA using restriction enzyme digestion |
| 05/30/2002 | US20020064790 Generating nucleotide sequence binding ligand; obtain ligandthat binds to nucleotide sequence, monitor binding activity of particle and sequences, recover ligands that utilizes reduced energy to bind sequences compare to wild type |
| 05/30/2002 | US20020064788 Systematic approach to mechanism-of-response analyses |
| 05/30/2002 | US20020064787 Methods for detecting mutations using primer extension for detecting disease |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064784 Monitoring drug binding activity; obtain cells, generate mutation in cell genome, detect killing mutation, recover protein generated |
| 05/30/2002 | US20020064782 Fluorescent nucleotides |
| 05/30/2002 | US20020064780 Detecting preferential nucleic acids; incubate target nucleic acids and ligands, separate bound particles, amplify nucleotide sequences, detect ligand |
| 05/30/2002 | US20020064779 Methods and kits for proximity probing |
| 05/30/2002 | US20020064778 Nuclelotide sequences for use in the detection of hepatitis virus |
| 05/30/2002 | US20020064777 Recombination repair gene, MIM, from arabidopsis thaliana |
| 05/30/2002 | US20020064776 Detecting human; obtain sample of nucleotide sequences of preferential human, store, recover nucleotide sequence sample in the event of death of preferential human |
| 05/30/2002 | US20020064775 Electrochemical detection of single base extension |
| 05/30/2002 | US20020064774 Apparatus, systems and method for assaying biological materials using an annular format |
| 05/30/2002 | US20020064773 Detecting preferential physical and hereditary genetic disorders; obtain sample, extract mitochondrial nucleotide sequences, compare to control, detect adjustment in seqences, evaluate for physical or genetic disorder |
| 05/30/2002 | US20020064772 In-situ methods for analyzing target sequences using linear beacons |
| 05/30/2002 | US20020064771 Viral enzymatic polypeptide and associations for use in the prevention of viral diseases and infections |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | US20020062835 Methods of modulating hair growth |
| 05/30/2002 | CA2764288A1 Clinically intelligent diagnostic devices and methods |
| 05/30/2002 | CA2454340A1 Methods and apparatus for producing gender enriched sperm |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/30/2002 | CA2429971A1 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | CA2429688A1 Method for testing susceptibility of tumor cell to anticancer agent |
| 05/30/2002 | CA2429652A1 Process for trapping and confining microorganisms in air using water-soluble polymers |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2429567A1 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |